+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Desmopressin, Others), By Disease Type, By Distribution Channel, By Gender, By End User, By Region, Competition Forecast & Opportunities, 2026

  • ID: 5311299
  • Report
  • April 2021
  • Region: Global
  • 116 pages
  • TechSci Research
The Global Bleeding Disorders Drugs Market is Expected to Grow at Robust Rate with a CAGR of 8.44% in Value Terms to Reach Usd24078.16 Million by 2026.

FEATURED COMPANIES

  • Baxter International Inc.
  • Bayer AG
  • Cadila Healthcare Ltd
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • MORE
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Bleeding Disorders Drugs Market is expected to grow at robust rate with a CAGR of 8.44% in value terms to reach USD24078.16 million by 2026 on account of increasing concerns for blood disorders among the worldwide population. Rising cases of bleeding disorders across the globe is a major driving force for the Global Bleeding Disorders Drugs Market in the forecast period, 2022-2026F. Moreover, increasing awareness towards the growing patient count and availability of treatment methods will support the growth of the Global Bleeding Disorders Drugs Market, positively.

The Global Bleeding Disorders Drugs Market is segmented by drug type, disease type, distribution channel, gender, end-user, and regional distribution. Based on disease type the market is further fragmented into Hemophilia A, Hemophilia B, Von Willebrand Disease, and others. Hemophilia A disease is the most common among the disease type and thus drives the Global Bleeding Disorders Drugs Market.

The drug type segment has been further segregated into Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants and Others. The Recombinant Coagulation Factor Concentrates dominated the overall market with 52.91% market share in 2020. The Region segment is fragmented into North America, Asia-Pacific, Europe, South America and Middle East and Africa. North America is expected to dominate the market whereas Asia-Pacific is projected to be the fastest leading region in the forecast period.

Some of the major competitors in the market are Bayer AG, Grifols S.A., Pfizer Inc., Octapharma AG, Ferring Pharmaceuticals SA, Sanofi SA, Baxter International Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceuticals Ltd., Novo Nordisk A/S, Novartis AG, CSL Limited, Teva Pharmaceutical Industries Ltd., Cadila Healthcare Ltd. and Johnson & Johnson International, Inc. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:
  • Historical Years: 2016 - 2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022 - 2026
Objective of the Study:
  • To analyze historical growth in the market size of the Global Bleeding Disorders Drugs Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Bleeding Disorders Drugs Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Bleeding Disorders Drugs Market based on drug type, disease type, distribution channel, end-user, and regional distribution.
  • To identify dominant region or segment in the Global Bleeding Disorders Drugs Market.
  • To identify drivers and challenges for the Global Bleeding Disorders Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Bleeding Disorders Drugs Market.
  • To identify and analyze the profiles of leading players operating in the Global Bleeding Disorders Drugs Market.
  • To identify key sustainable strategies adopted by market players in the Global Bleeding Disorders Drugs Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers, suppliers, and service providers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufactures which could not be identified due to the limitations of secondary research. The publisher analyzed the manufactures, distribution channels and presence of all major players across the globe.

The publisher calculated the market size of the Global Bleeding Disorders Drugs Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Bleeding disorders treatment drugs vendors, end-users, service providers and other stakeholders
  • Distributers and suppliers of bleeding disorders treatment products and services and other stakeholders
  • Organizations, forums, and alliances related to bleeding disorders treatment
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Bleeding Disorders Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Bleeding Disorders Drugs Market, By Drug Type:
  • Plasma-derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others
Global Bleeding Disorders Drugs Market, By Disease Type:
  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others
Global Bleeding Disorders Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
Global Bleeding Disorders Drugs Market, By Gender
  • Male
  • Female
Global Bleeding Disorders Drugs Market, By End-User:
  • Hospitals
  • Hemophilia Treatment Centers
  • Research Institutes
  • Others
Global Bleeding Disorders Drugs Market, By Region:
  • North America
  • APAC
  • Europe
  • South America
  • MEA
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bleeding Disorders Drugs Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter International Inc.
  • Bayer AG
  • Cadila Healthcare Ltd
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • MORE

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bleeding Disorders Drugs Market

4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness
5.2. Patients Satisfaction
5.3. Factors driving the global bleeding disorder market

6. Global Bleeding Disorders Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others)
6.2.2. By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others)
6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)
6.2.4. By Gender (Male v/s Female)
6.2.5. By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others)
6.2.6. By Company (2020)
6.2.7. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3. Product Market Map

7. North America Bleeding Disorders Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Disease Type
7.2.3. By Distribution Channel
7.2.4. By Gender
7.2.5. By End User
7.2.6. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Bleeding Disorders Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Disease Type
7.3.1.2.3. By Distribution Channel
7.3.1.2.4. By Gender
7.3.1.2.5. By End User
7.3.2. Canada Bleeding Disorders Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Disease Type
7.3.2.2.3. By Distribution Channel
7.3.2.2.4. By Gender
7.3.2.2.5. By End User
7.3.3. Mexico Bleeding Disorders Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Disease Type
7.3.3.2.3. By Distribution Channel
7.3.3.2.4. By Gender
7.3.3.2.5. By End User

8. Europe Bleeding Disorders Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Disease Type
8.2.3. By Distribution Channel
8.2.4. By Gender
8.2.5. By End User
8.2.6. By Country (Germany; United Kingdom; France; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. Germany Bleeding Disorders Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Disease Type
8.3.1.2.3. By Distribution Channel
8.3.1.2.4. By Gender
8.3.1.2.5. By End User
8.3.2. United Kingdom Bleeding Disorders Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Disease Type
8.3.2.2.3. By Distribution Channel
8.3.2.2.4. By Gender
8.3.2.2.5. By End User
8.3.3. France Bleeding Disorders Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Disease Type
8.3.3.2.3. By Distribution Channel
8.3.3.2.4. By Gender
8.3.3.2.5. By End User
8.3.4. Italy Bleeding Disorders Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Disease Type
8.3.4.2.3. By Distribution Channel
8.3.4.2.4. By Gender
8.3.4.2.5. By End User
8.3.5. Spain Bleeding Disorders Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Disease Type
8.3.5.2.3. By Distribution Channel
8.3.5.2.4. By Gender
8.3.5.2.5. By End User

9. Asia Pacific Bleeding Disorders Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Disease Type
9.2.3. By Distribution Channel
9.2.4. By Gender
9.2.5. By End User
9.2.6. By Country (India; China; Japan; Australia; South Korea)
9.3 Asia Pacific: Country Analysis
9.3.1 India Bleeding Disorders Drugs Market Outlook
9.3.1.1 Market Size & Forecast
9.3.1.1.1 By Value
9.3.1.2 Market Share & Forecast
9.3.1.2.1 By Drug Type
9.3.1.2.2 By Disease Type
9.3.1.2.3 By Distribution Channel
9.3.1.2.4 By Gender
9.3.1.2.5 By End User
9.3.2 China Bleeding Disorders Drugs Market Outlook
9.3.2.1 Market Size & Forecast
9.3.2.1.1 By Value
9.3.2.2 Market Share & Forecast
9.3.2.2.1 By Drug Type
9.3.2.2.2 By Disease Type
9.3.2.2.3 By Distribution Channel
9.3.2.2.4 By Gender
9.3.2.2.5 By End User
9.3.3 Japan Bleeding Disorders Drugs Market Outlook
9.3.3.1 Market Size & Forecast
9.3.3.1.1 By Value
9.3.3.2 Market Share & Forecast
9.3.3.2.1 By Drug Type
9.3.3.2.2 By Disease Type
9.3.3.2.3 By Distribution Channel
9.3.3.2.4 By Gender
9.3.3.2.5 By End User
9.3.4 Australia Bleeding Disorders Drugs Market Outlook
9.3.4.1 Market Size & Forecast
9.3.4.1.1 By Value
9.3.4.2 Market Share & Forecast
9.3.4.2.1 By Drug Type
9.3.4.2.2 By Disease Type
9.3.4.2.3 By Distribution Channel
9.3.4.2.4 By Gender
9.3.4.2.5 By End User
9.3.5 South Korea Bleeding Disorders Drugs Market Outlook
9.3.5.1 Market Size & Forecast
9.3.5.1.1 By Value
9.3.5.2 Market Share & Forecast
9.3.5.2.1 By Drug Type
9.3.5.2.2 By Disease Type
9.3.5.2.3 By Distribution Channel
9.3.5.2.4 By Gender
9.3.5.2.5 By End User

10 South America Bleeding Disorders Drugs Market Outlook
10.1 Market Size & Forecast
10.1.1 By Value
10.2 Market Share & Forecast
10.2.1 By Drug Type
10.2.2 By Disease Type
10.2.3 By Distribution Channel
10.2.4 By Gender
10.2.5 By End User
10.2.6 By Country (Brazil; Argentina; Colombia)
10.3 South America: Country Analysis
10.3.1 Brazil Bleeding Disorders Drugs Market Outlook
10.3.1.1 Market Size & Forecast
10.3.1.1.1 By Value
10.3.1.2 Market Share & Forecast
10.3.1.2.1 By Drug Type
10.3.1.2.2 By Disease Type
10.3.1.2.3 By Distribution Channel
10.3.1.2.4 By Gender
10.3.1.2.5 By End User
10.3.2 Argentina Bleeding Disorders Drugs Market Outlook
10.3.2.1 Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2 Market Share & Forecast
10.3.2.2.1 By Drug Type
10.3.2.2.2 By Disease Type
10.3.2.2.3 By Distribution Channel
10.3.2.2.4 By Gender
10.3.2.2.5 By End User
10.3.3 Colombia Bleeding Disorders Drugs Market Outlook
10.3.3.1 Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2 Market Share & Forecast
10.3.3.2.1 By Drug Type
10.3.3.2.2 By Disease Type
10.3.3.2.3 By Distribution Channel
10.3.3.2.4 By Gender
10.3.3.2.5 By End User

11. Middle East and Africa Bleeding Disorders Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Disease Type
11.2.3. By Distribution Channel
11.2.4. By Gender
11.2.5. By End User
11.2.6. By Country (UAE; Saudi Arabia; South Africa)
11.3. MEA: Country Analysis
11.3.1. Saudi Arabia Bleeding Disorders Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Disease Type
11.3.1.2.3. By Distribution Channel
11.3.1.2.4. By Gender
11.3.1.2.5. By End User
11.3.2. UAE Bleeding Disorders Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Disease Type
11.3.2.2.3. By Distribution Channel
11.3.2.2.4. By Gender
11.3.2.2.5. By End User
11.3.3. South Africa Bleeding Disorders Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Disease Type
11.3.3.2.3. By Distribution Channel
11.3.3.2.4. By Gender
11.3.3.2.5. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Bayer AG
14.2.2. Pfizer Inc.
14.2.3. Grifols S.A.
14.2.4. Octapharma AG
14.2.5. Ferring Pharmaceuticals SA
14.2.6. Sanofi SA
14.2.7. Baxter International Inc.
14.2.8. F. Hoffmann-La Roche Ltd.
14.2.9. Takeda Pharmaceuticals Ltd.
14.2.10. Novo Nordisk A/S
14.2.11. Novartis AG
14.2.12. CSL Limited
14.2.13. Teva Pharmaceutical Industries Ltd.
14.2.14. Cadila Healthcare Ltd
14.2.15. Johnson & Johnson International Inc.

15. Strategic Recommendations

16. About the Publisher & Disclaimer

List of Figures
Figure 1: Global Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 3: Global Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 4: Global Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 5: Global Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 6: Global Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 7: Global Bleeding Disorders Drugs Market, Market Map, By Region, By Value, 2016-2026F
Figure 8: North America Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 9: North America Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 10: North America Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 11: North America Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 12: North America Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 13: North America Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 14: United States Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 15: United States Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 16: United States Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 17: United States Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 18: United States Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 19: United States Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 20: Canada Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 21: Canada Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 22: Canada Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 23: Canada Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 24: Canada Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 25: Canada Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 26: Mexico Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 27: Mexico Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 28: Mexico Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 29: Mexico Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 30: Mexico Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 31: Mexico Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 32: Europe Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 33: Europe Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 34: Europe Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 35: Europe Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 36: Europe Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 37: Europe Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 38: Germany Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 39: Germany Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 40: Germany Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 41: Germany Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 42: Germany Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 43: Germany Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 44: United Kingdom Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 45: United Kingdom Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 46: United Kingdom Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 47: United Kingdom Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 48: United Kingdom Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 49: United Kingdom Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 50: France Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 51: France Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 52: France Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 53: France Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 54: France Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 55: France Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 56: Italy Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 57: Italy Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 58: Italy Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 59: Italy Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 60: Italy Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 61: Italy Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 62: Spain Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 63: Spain Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 64: Spain Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 65: Spain Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 66: Spain Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 67: Spain Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 68: Asia Pacific Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 69: Asia Pacific Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 70: Asia Pacific Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 71: Asia Pacific Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 72: Asia Pacific Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 73: Asia Pacific Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 74: India Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 75: India Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 76: India Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 77: India Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 78: India Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 79: India Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 80: China Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 81: China Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 82: China Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 83: China Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 84: China Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 85: China Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 86: Japan Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 87: Japan Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 88: Japan Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 89: Japan Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 90: Japan Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 91: Japan Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 92: Australia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 93: Australia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 94: Australia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 95: Australia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 96: Australia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 97: Australia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 98: South Korea Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 99: South Korea Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 100: South Korea Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 101: South Korea Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 102: South Korea Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 103: South Korea Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 104: South America Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 105: South America Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 106: South America Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 107: South America Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 108: South America Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 109: South America Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 110: Brazil Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 111: Brazil Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 112: Brazil Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 113: Brazil Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 114: Brazil Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 115: Brazil Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 116: Argentina Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 117: Argentina Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 118: Argentina Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 119: Argentina Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 120: Argentina Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 121: Argentina Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 122: Colombia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 123: Colombia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 124: Colombia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 125: Colombia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 126: Colombia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 127: Colombia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 128: Middle East and Africa Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 129: Middle East and Africa Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 130: Middle East and Africa Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 131: Middle East and Africa Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 132: Middle East and Africa Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 133: Middle East and Africa Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 134: Saudi Arabia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 135: Saudi Arabia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 136: Saudi Arabia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 137: Saudi Arabia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 138: Saudi Arabia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 139: Saudi Arabia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 140: UAE Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 141: UAE Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 142: UAE Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 143: UAE Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 144: UAE Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 145: UAE Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
Figure 146: South Africa Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 147: South Africa Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
Figure 148: South Africa Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
Figure 149: South Africa Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 150: South Africa Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
Figure 151: South Africa Bleeding Disorders Drugs Market Share, By End User, 2016-2026F

Note: Product cover images may vary from those shown
  • Bayer AG
  • Pfizer Inc.
  • Grifols S.A.
  • Octapharma AG
  • Ferring Pharmaceuticals SA
  • Sanofi SA
  • Baxter International Inc.
  • F. Hoffmann-La Roche Ltd.
  • Takeda Pharmaceuticals Ltd.
  • Novo Nordisk A/S
  • Novartis AG
  • CSL Limited
  • Teva Pharmaceutical Industries Ltd.
  • Cadila Healthcare Ltd
  • Johnson & Johnson International Inc.
Note: Product cover images may vary from those shown
Adroll
adroll